Fig. 4.
Evolution of lameness in dogs using the Bioarth scoring scale at days 0, 30, 90, and 180 post-treatment with mesenchymal stem cells. The control group is also shown for comparison
Evolution of lameness in dogs using the Bioarth scoring scale at days 0, 30, 90, and 180 post-treatment with mesenchymal stem cells. The control group is also shown for comparison